GLP-1 Receptor Agonist Market Set to Reach USD 7.9 Billion by 2036, India - CAGR 8.4%, China - CAGR 7.1%, Germany - CAGR 6.6%
The global GLP-1 receptor agonist market growing from USD 3 billion in 2026 to USD 7.9 billion by 2036, expanding at a CAGR of 11.7% during the forecast period. The market is gaining momentum as type 2 diabetes and obesity become more widespread, while GLP-1 therapies offer combined benefits for blood sugar management, appetite reduction, and weight control. The market is expected to add USD...
0 Commentarios 0 Acciones 3 Views 0 Vista previa